An older adult patient with limited financial resources is p…
An older adult patient with limited financial resources is prescribed a new medication for chronic renal insufficiency. Which factor should the nurse practitioner prioritize when deciding whether to continue this medication? Reviewing the patient’s medication list for possible drug–drug interactions The drug’s cost and renal dosing requirements, to ensure safety and adherence Confirming the medication is available on the patient’s insurance formulary Following guideline-recommended therapy, while considering whether it fits the patient’s context
Read DetailsFather Corp. held 80% of Son Inc., which, in turn, owned 80%…
Father Corp. held 80% of Son Inc., which, in turn, owned 80% of Grandson Co. Excess amortization expense was not required by any of these acquisitions. Separate net income figures (without investment income) as well as intra-entity gross profits (before deferral) included in the income for the current year follow: Father Corp. Son Inc. Grandson Co. Separate net income $560,000 $420,000 $280,000 Intra-entity gross profits 70,000 42,000 84,000 The net income attributable to the noncontrolling interest of Son Inc. is calculated to be:
Read Details1. Odyssey Co. sold inventory to its wholly-owned subsidiary…
1. Odyssey Co. sold inventory to its wholly-owned subsidiary, Civic Co. The inventory cost $40,000 and was sold to Civic for $58,000. For consolidation reporting purposes, when is the $18,000 intra-entity gross profit recognized?
Read DetailsOn January 1, 2024, Power acquired a 60% ownership in Streng…
On January 1, 2024, Power acquired a 60% ownership in Strength for $372. Strength’s book value on that date consisted of common stock of $100 and retained earnings of $220. Also, the acquisition-date fair value of the 40 percent NCI was $248. Strength held patents with a 10-year remaining life that were undervalued within the accounting records by $70 and an unrecorded customer list with a 15-year remaining life assessed at a $45 fair value. In 2025, Power sold inventories to Strength for $160, although the original cost was only $112. At year-end, $40 of the goods (at the transfer price) were still on hand. Please fill out the following blanks. (1) FV of Consideration Transferred [Payment] FV of NCI at the Acquisition date [FVNCI] Total FV [totalFV] – Book Value of Strength [BV] Excess Payment [ExcessPay] FV adjustments: Remaining life Annual Amortization Patents [Patent] 10 [PatentAmort] Customer List [CustomerList] 15 [CustAMORT] Goodwill [GW] (2) The unrealized gain from the intra-entity inventory transaction in 2025 is: [UnrealizedGain] (3) Please complete the 2025 worksheet below: Power Strength DR CR NCI Sales (700) (335) TI [TID] Cost of goods sold 460 205 G [GD] TI [TIC] Operating expenses 188 70 E [ED] Income of Strength (28) I [ID] Separate income (80) (60) Consolidated net income to NCI [NCII] to parent Retained earnings, 1/1 (695) (280) S [SD] Net income (above) (80) (60) Dividends paid 45 15 D [DC] [NCID] Retained earnings, 12/31 (730) (325) Cash and receivables 248 148 Inventory 233 129 G [GC] Investment in Strength 421 D [DD] S [SC1] A [AC1] I [IC] Buildings (net) 308 202 Equipment (net) 220 86 Patents (net) 20 A [AD1] E [EC1] Customer list A [AD2] E [EC2] Goodwill A [AD3] Total assets 1,430 585 Liab. (400) (160) Common stock (300) (100) S [SD2] Noncontrolling interest 1/1 S [SC2] A [AC2] [NCIBeg] Noncontrolling interest 12/31 [NCIEND] Retained earnings, 12/31 (730) (325) Total liabilities and equities (1,430) (585)
Read Details